May health in a €10M series B extension led by Nexpring Health, joined by existing shareholders Sofinnova Partners, Bpifrance, and Trill Impact.
02 March 2026
02 March 2026
Total investments received (USD): 48.05M
Round value (USD): 11.83M
Company: May health
Related deals
Lifeaz in a €13M series A round with Mutuelles Impact, BNP Paribas, GO CAPITAL, and Mirova, an affiliate of Natixis
Investments
01 February 2026
4Moving Biotech raised a €12 million financing with 4P-Pharma, Fondation Arthritis, SATT Lutech, Business Angels, Family Offices in France
Investments
17 January 2026
ErVimmune raised €17 million Series A financing with Seventure and SPRIM Global
Investments
06 January 2026
BrightHeart raised $12.8m Series A funding co-led by Odyssée Venture and GO Capital, joined by and Sofinnova Partners, Mussallem, Lift Value, Side Angels
Investments
08 December 2025
Damae Medical raised €15M series B led by Creadev, joined by Kurma Partners, ISPB, BNP Paribas Développement
Investments
11 November 2025
Belgium
Netherlands
Austria
Germany
Switzerland
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Ireland
Italy
Portugal
Spain
United Kingdom